Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04817007
Title A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

myelofibrosis

Therapies

BMS986158 + Ruxolitinib

BMS986158 + CYC065

BMS986158

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU


No variant requirements are available.